Hearing Loss Trial, Recruiting NCT05962359 Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago Condition: Hearing Loss
Back to Hearing Loss

Hearing Loss Trial, Recruiting

NCT05962359
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Arm 1:

  • Children who have a type of permanent hearing loss (called sensorineural hearing loss) in both ears and who meet the medical standards for receiving cochlear implants, and who are 5 years old or younger when the cochlear implant evaluation starts
  • Children whose main language spoken at home is English or Spanish

Arm 2:

  • Children who have permanent hearing loss in both ears and who meet the medical standards for receiving cochlear implants
  • Children who are 36 months (3 years) old or younger when treatment begins
  • Children whose family mainly speaks English at home
  • Children who have at least one parent or caregiver willing to take part in the study who understands spoken English
  • Children who are exposed to spoken language by at least one parent or caregiver at home (whether through speech alone or a combination of speech and signing)

Who may not be able to join:

Arm 1:

  • Children with serious physical movement or thinking/learning difficulties that would make it hard to measure their progress
  • Children where only a limited portion of the cochlear implant can be inserted, in a way likely to significantly affect their hearing development
  • Children whose hearing loss was caused by bacterial meningitis
  • Children whose main home language is not English or Spanish

Arm 2:

  • Children with serious physical movement or thinking/learning difficulties that would make it hard to measure their progress
  • Children where only a limited portion of the cochlear implant can be inserted, in a way likely to significantly affect their hearing development
  • Children whose hearing loss was caused by bacterial meningitis
  • Children whose main home language is not English
  • Children with a diagnosis or medical condition (separate from hearing loss) that is expected to affect language development
  • Children who have a problem with the hearing nerve in the implanted ear, or a severe abnormality in the structure of the inner ear
  • Children who already have some spoken language and score above the 25th percentile on a standard language assessment called the CDI (Words and Sentences section)
  • Children who have already had more than two months of experience using a cochlear implant before the study treatment begins

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Nancy M Young, MD, Ann & Robert H Lurie Children's Hospital of Chicago

Phone: 312-227-6812

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago
Registry
ClinicalTrials.gov
Start date
23 January 2023
Est. completion
23 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Preschool Language Scales, Fifth Edition (PLS-5); Preschool Language Scales, Fifth Edition (PLS-5); Preschool Language Scales, Fifth Edition (PLS-5); Preschool Language Scales, Fifth Edition (PLS-5); Expressive One-Word Picture Vocabulary Test, Fourth Edition (EOWPVT-4); Expressive One-Word Picture Vocabulary Test, Fourth Edition (EOWPVT-4); Expressive One-Word Picture Vocabulary Test, Fourth Edition (EOWPVT-4); Expressive One-Word Picture Vocabulary Test, Fourth Edition (EOWPVT-4); MacArthur-Bates Communicative Development Inventory (CDI); MacArthur-Bates Communicative Development Inventory (...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov